Market Overview

CytRx Announces Issuance of Key U.S. Patent Covering INNO-206 Linker Technology

CytRx Corporation (Nasdaq: CYTR) today announced that the U.S. Patent and Trademark Office (USPTO) has issued a key patent covering the tumor-targeting conjugate INNO-206 linker platform technology and INNO-206 pharmaceutical compositions.

Posted-In: News FDA

 

Most Popular

Related Articles (CYTR)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free

Benzinga Professional